StoneX Group (SNEX) amends 13F, fixes under‑reported holdings
Filing Impact
Filing Sentiment
Form Type
13F-HR/A
Rhea-AI Filing Summary
StoneX Group Inc. filed an amended Form 13F (Amendment No. 2) restating prior quarterly reports after identifying under‑reported holdings from Q4 2021 through Q1 2025. The amendment lists 37 Form 13F information table entries with a total value of $31,429,579 and attributes the errors to four causes identified by the firm.
The filing names the affected reporting managers and explains the four error causes: missing market‑making accounts; an Excel XLOOKUP vs SUMIF formula error; failure to implement an SEC rounding rule; and Excel conversion of CUSIPs to scientific notation.
Positive
- None.
Negative
- None.
FAQ
What did StoneX Group (SNEX) amend in its Form 13F filing?
StoneX Group filed Amendment No. 2 to restate prior 13F reports. The amendment corrects under‑reported securities, shares and market values covering Q4 2021 through Q1 2025 and updates the Form 13F information table to reflect corrected holdings and values.
How many holdings and what total value are in the amended 13F?
The amended Form 13F lists 37 information table entries. The Form 13F information table value total is $31,429,579, rounded to the nearest dollar as shown on the summary page of the amendment.
Which reporting managers were affected by the StoneX 13F errors?
The filing states errors involved all Other Reporting Managers: StoneX Advisors Inc., StoneX Financial Inc., and Trust Advisory Group, Ltd., which contributed to under‑reporting across the affected quarters.
What specific causes did StoneX identify for the reporting errors?
StoneX identified four causes: (1) missing market‑making accounts, (2) an Excel formula error using XLOOKUP instead of SUMIF, (3) failure to implement SEC rounding rule change, and (4) Excel converting CUSIPs with an "E" into scientific notation.
Does the amendment state when the restated quarters occurred?
Yes. The amendment covers under‑reporting in quarterly filings from Q4 2021 through Q1 2025, as disclosed in the explanatory section describing the scope of the internal review and the affected periods.